General Biomarker Research
Groundbreaking Discoveries
New technologies allow comprehensive blood sampling that historically was not available or expected because of the large volume of blood required and associated costs. Clinicians are now able to get a more comprehensive picture of the biological responses associated with specific clinical conditions. Biomarker research and applications are among the fastest-growing topics in medical science, but represent a new approach for many physicians.
There are hundreds of published studies viewable here that document the importance of blood-based biomarkers in the identification, prevention and treatment of diseases at their earliest, most treatable stages.
Clinical Applications in Pharmaceutical Development
Many diseases and clinical conditions can be identified and defined by abnormal levels of specific blood chemicals.
Use of blood-based biomarkers allows for the early discovery of the benefits and dangers of new drug therapies. These biomarkers may identify the multiple sources of positive and negative effects of drugs and drug interactions during both preclinical and clinical trials.
Biomarkers may also be used to help identify the patients most likely to respond to a given therapy and the biochemical reason for that response, making clinical trials more successful and effective.
Clinical Applications in Patient Care
Early identification and treatment of clinical conditions provide the best chance of a successful outcome, often with less long-term expense. Biomarker testing reveals and measures minute shifts in blood components. The testing can focus on the identified blood profiles for many individual clinical conditions, including cancer, cardiovascular risk and autoimmune diseases. It can also measure specific biochemicals including hormones, cytokines/chemokines, acute phase reactants, clotting proteins, growth factors and tissue modeling factors.
Reliability and Credibility
Blood-based biomarkers are increasingly used by researchers for the world’s leading pharmaceutical and biotechnology companies, as well as universities and government laboratories. The use of blood-based biomarkers has proven to be cost-effective and reliable through years of research, development and commercial application.
Annual examinations, imaging technologies and other diagnostic tests evaluate a limited number of organ systems and screen for certain diseases. Blood-based biomarkers may identify potentially serious conditions and risk factors, often before symptoms even appear, so physicians can track and treat these conditions more effectively.
Of Mice and Men, It's all about the phenotype.
Ralph L. McDade, Ph.D.
Rules Based Medicine
Blood based diagnostics is already a billion dollar industry. Physicians today place an enormous amount of emphasis on the results of blood tests. Why? Because everything that happens in your body manifests itself in the blood. Our approach at Rules-Based Medicine is to develop and use large immunoassay testing panels which we call Multi-Analyte Profiles or MAPs to identify these biomarker patterns in blood. These MAPs and their application in diagnostics and drug development are the subject of this presentation.
Serum biomarkers for early detection of Ovarian Cancer
Anna Lokshin, Ph.D.
University of Pittsburgh Cancer Institute
Ovarian cancer is the fourth most frequent cause of death in women in Europe and the U.S. Currently, only 20% of ovarian cancers are found at the early stage when they are most treatable. A blood test that can detect and reliably discriminate between ovarian cancer and benign pelvic disease would be very valuable. We are using a multiplexed serum assay in order to detect malignant ovarian cancer at the earliest stage and have developed a multi-biomarker screening test that may diagnose ovarian cancer up to 4 years prior to clinical diagnosis.
These educational modules are designed with tools for viewing and navigation from Articulate. To use the educational modules, select from the list above and the presentation will open in a new browser window. The presentation is set to begin playing as the first slide is being downloaded or you can use the outline or thumbnail navigation on the left to select a slide. The audio level can be adjusted from the tool bar in the presentation or by using your computer's volume controls.
The Send-A-Link tool creates an emailed link that can be freely distributed for non-commercial use. All other rights reserved. For inquiries, contact The Biophysical Corporation.